Calumet, INC /DE 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. reported a second quarter 2026 net loss of $95.9 million, impacted by non-cash RINs and mark-to-market items, though Adjusted EBITDA with Tax Attributes reached $175.2 million.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced the results of its 2026 Annual Meeting of Stockholders, including the election of directors and the ratification of its independent auditor.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. reported a first quarter 2026 net loss of $317.0 million, impacted by non-cash items and operational downtime, though the company anticipates improved margins.
NASDAQ
CLMT
Calumet, INC /DEJennifer Straumins will not seek re-election to Calumet's Board of Directors, retiring at the end of her current term.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced the closing of a $150 million private placement of 9.75% Senior Notes due 2031, with proceeds earmarked for revolving credit facility repayment.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced the pricing of $150 million in 9.75% Senior Notes due 2031 in a private placement, with proceeds intended to repay its revolving credit facility.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced its intent to offer $150 million in 9.75% Senior Notes due 2031 to repay revolving credit facility borrowings.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. reported a significant reduction in net loss for fiscal year 2025, alongside substantial debt reduction and record production in its Specialty Products & Solutions and Montana Renewables segments.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. has amended its credit agreement, extending the maturity date to 2031 and adjusting borrowing commitments, while also enabling new inventory financing transactions.
NASDAQ
CLMT
Calumet, INC /DECalumet Specialty Products Partners and Calumet Finance Corp. successfully closed an upsized $405 million private placement of 9.75% Senior Notes due 2031, with proceeds earmarked to redeem higher-interest 2026 and 2027 notes.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced the pricing of an upsized $405 million private placement of 9.75% Senior Notes due 2031 to redeem existing higher-interest and shorter-term debt.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced a private placement of $350 million in senior unsecured notes due 2031 to redeem existing higher-interest debt, aiming to optimize its capital structure.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced preliminary unaudited fiscal year 2025 results, including a net loss, but highlighted significant debt reduction and operational improvements.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. reported a significant turnaround in third-quarter 2025 financial results, driven by strong specialty product sales and progress in its Montana Renewables segment.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced that its unaudited interim financial statements for Q1 and Q2 2025 can no longer be relied upon due to a misclassification error in cash flow reporting.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. reported a significantly wider net loss for Q2 2025, despite operational improvements in its Specialties and Montana Renewables segments and ongoing cost reductions.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced a $120 million sale and leaseback transaction for its Shreveport refinery assets, generating $80 million in net proceeds to partially redeem its 11.00% Senior Notes due 2026.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announced the successful outcomes of its 2025 Annual Meeting of Stockholders, including the election of Class I directors, advisory approval of executive compensation, and ratification of its independent accounting firm.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. has appointed John R. Krutz as its new Chief Accounting Officer, effective May 21, 2025, while David A. Lunin remains CFO.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announces the termination of Board Chair Stephen Mawer's stock trading plan, which was adopted to comply with Rule 10b5-1(c) and resulted in the sale of 10,965 shares prior to termination.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. reported a net loss for Q1 2025 but highlighted progress in Montana Renewables' SAF capacity expansion and debt reduction efforts.
NASDAQ
CLMT
Calumet, INC /DECalumet Inc. ended its Equity Distribution Agreement with BMO Capital Markets and announced the resignation of its Chief Accounting Officer, effective April 15, 2025.
NASDAQ
CLMT
Calumet, INC /DEJames S. Carter and Daniel L. Sheets will retire from Calumet Inc.'s Board of Directors at the end of their terms.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. reported a net loss for Q4 2024 but saw growth in its Performance Brands segment and announced the sale of its Royal Purple industrial business to reduce debt.
NASDAQ
CLMT
Calumet, INC /DE8-K: Calumet's Montana Renewables Secures $782 Million DOE Loan, Terminating Existing Debt Facilities
Calumet's subsidiary, Montana Renewables, received $782 million from a $1.44 billion DOE loan facility, leading to the termination of several existing debt agreements.
NASDAQ
CLMT
Calumet, INC /DECalumet Inc. announces the resumption of funding for its Montana Renewables subsidiary's U.S. Department of Energy (DOE) loan, with the first tranche of approximately $782 million expected to be completed next week.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. has announced the issuance of $100 million in new senior notes to redeem a portion of its existing 2026 notes.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. announces the pricing of a $100 million private placement of 9.75% Senior Notes due 2028 to redeem a portion of its 2026 Senior Notes.
NASDAQ
CLMT
Calumet, INC /DE8-K: Calumet Announces $65 Million At-the-Market Equity Offering and $100 Million Private Debt Placement
Calumet, Inc. has announced a $65 million at-the-market equity offering and a $100 million private placement of senior notes to redeem existing debt.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. releases preliminary Q4 2024 financial results, anticipating a net loss between $54 million and $24 million and Adjusted EBITDA between $45 million and $60 million, while also highlighting progress on the DOE loan and operational milestones.